Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia

被引：0
|
作者：
Sirvent, JLG [1 ]
Socas, MMA [1 ]
Calzadilla, CH [1 ]
Lirola, AML [1 ]
Valls, MRA [1 ]
机构：
[1] Hosp Univ Canarias, Lab Serv, Infect Dis Serv, Tenerife, Spain
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 40卷 / 01期
关键词：
D O I：
10.1097/01.qai.0000174650.33159.22
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：111 / 113
页数：3
相关论文
共 50 条
  • [21] Genotypic resistance in HIV-1 infected patients with persistent low-level viremia
    Parra-Ruiz, Jorge
    Alvarez, Marta
    Chueca, Natalia
    Pena, Alejandro
    Pasquau, Juan
    Angel Lopez-Ruz, Miguel
    del Carmen Maroto, Maria
    Hernandez-Quero, Jose
    Garcia, Federico
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (02): : 75 - 80
  • [22] Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: A prospective cohort study
    Ding, Haibo
    Xu, Junjie
    Liu, Jing
    Wang, Qi
    Kang, Jing
    Li, Xiaolin
    Zhang, Zining
    Han, Xiaoxu
    Jiang, Yongjun
    Geng, Wenqing
    Shang, Hong
    HIV MEDICINE, 2022, 23 : 64 - 71
  • [23] Low-level HIV viremia is associated with low antiretroviral prescription refill rates and social deprivation
    de Bouille, Jeanne Goupil
    Collignon, Marion
    Capsec, Jean
    Guillon, Leslie
    Le Moal, Gwenael
    Barin, Francis
    Roncato, Mariam
    Hocqueloux, Laurent
    Stefic, Karl
    Bernard, Louis
    Gras, Guillaume
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2021, 33 (11): : 1445 - 1450
  • [24] HIV-1 RNA and DNA Genotyping Drug Resistance Detection in Patients with Low-Level Viremia in Liangshan, China
    Cao, Bianchuan
    Liu, Mei
    Jiang, Tao
    Yu, Qinghua
    Yuan, Tianru
    Ding, Ping
    Zhou, Xian
    Huang, Fuli
    Huang, Yongmao
    Jiang, Jianning
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2023, 39 (08) : 429 - 435
  • [25] Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy
    Fleming, Julia
    Mathews, W. Christopher
    Rutstein, Richard M.
    Aberg, Judith
    Somboonwit, Charurut
    Cheever, Laura W.
    Berry, Stephen A.
    Gebo, Kelly A.
    Moore, Richard D.
    AIDS, 2019, 33 (13) : 2005 - 2012
  • [26] Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women
    Delwart, Eric
    Bernardin, Flavien
    Lee, Tzong-Hae
    Winkelman, Valerie
    Liu, Chenglong
    Sheppard, Haynes
    Liu, Albert
    Greenblatt, Ruth
    Anastos, Katryn
    DeHovitz, Jack
    Nowicki, Marek
    Cohen, Mardge
    Golub, Elizabeth T.
    Barbour, Jason
    Buchbinder, Susan
    Busch, Michael P.
    AIDS, 2011, 25 (05) : 619 - 623
  • [27] Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
    Gaifer, Zied
    Boulassel, Mohamed-Rachid
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2020, 19
  • [28] Extending HIV Drug Resistance Testing to Low Levels of Plasma Viremia
    Richman, Douglas D.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (08) : 1174 - 1175
  • [29] Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients
    Delaugerre, Constance
    Gallien, Sebastien
    Flandre, Philippe
    Mathez, Dominique
    Amarsy, Rishma
    Ferret, Samuel
    Timsit, Julie
    Molina, Jean-Michel
    de Truchis, Pierre
    PLOS ONE, 2012, 7 (05):
  • [30] Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
    Palmer, Sarah
    Malclarelli, Frank
    Wiegand, Ann
    Bernstein, Barry
    Hanna, George J.
    Brun, Scott C.
    Kempf, Dale J.
    Mellors, John W.
    Coffin, John M.
    King, Martin S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) : 3879 - 3884
12345